This webinar will describe the role that the reference material manufacturer plays by providing the tools needed to respond to the current opioid epidemic.
Whether by rapidly providing authentic reference standards of novel emerging drugs of abuse or the analytical instrumentation necessary to identify them in casework, private forensic industry partners play a critical role in the response to the opioid crisis. The speed at which novel psychoactive substances are encountered in forensic casework has significantly increased over the past few years. To aid the forensic community in the identification of new substances in seized bulk materials and counterfeit pills or metabolites in bodily fluids, reference material manufacturers such as Cayman Chemical have had quite the challenge to synthesize and qualify materials in the most expedient manner.
Rapid communication and collaboration with industry is needed to adequately respond to the current crisis. This webinar will describe the role that the reference material manufacturer plays by providing the tools needed to respond to the current opioid epidemic. Recent examples of how this has been successful will be presented as well as tips for strengthening this connection.
- To describe the current relationship Cayman Chemical has with the forensic community and discuss how that can be strengthened.
- To discuss the synthesis, standardized naming, and safety aspects of fentanyl derivatives.
- To discuss the variety of quality control measures in place to offer ISO 17025 and ISO Guide 34 standards.
- To share what services and free webtools (such as spectral libraries) are available to aid in the identification of unknown cases.
Funding for this webinar has been brought to you by the National Institute of Justice’s Forensic Technology Center for Excellence.